Your browser doesn't support javascript.
loading
CDK8/19 inhibition induces premature G1/S transition and ATR-dependent cell death in prostate cancer cells.
Nakamura, Akito; Nakata, Daisuke; Kakoi, Yuichi; Kunitomo, Mihoko; Murai, Saomi; Ebara, Shunsuke; Hata, Akito; Hara, Takahito.
Afiliación
  • Nakamura A; Oncology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
  • Nakata D; Oncology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
  • Kakoi Y; Oncology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
  • Kunitomo M; Oncology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
  • Murai S; Oncology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
  • Ebara S; Oncology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
  • Hata A; Bio Molecular Research Laboratories, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
  • Hara T; Oncology Drug Discovery Unit, Takeda Pharmaceutical Company Limited, Kanagawa, Japan.
Oncotarget ; 9(17): 13474-13487, 2018 Mar 02.
Article en En | MEDLINE | ID: mdl-29568371
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Idioma: En Revista: Oncotarget Año: 2018 Tipo del documento: Article País de afiliación: Japón